On Feb 24, 2026, CDNA reported earnings of 0.12 USD per share (EPS) for Q4 25, missing the estimate of 0.24 USD, resulting in a -50.80% surprise. Revenue reached 108.39 million, compared to an expected 105.31 million, with a 2.92% difference. The market reacted with a -1.85% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of 0.13 USD, with revenue projected to reach 104.33 million USD, implying an increase of 8.33% EPS, and decrease of -3.74% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+15.51%
OSR Holdings, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.16
Surprise
-56.86%
Synergy CHC Corp. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
$0.01
Actual
-$0.72
Surprise
-7158.82%
Co-Diagnostics, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$3.67
Actual
-$3.64
Surprise
+0.87%
FAQ
What were CareDx, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, CareDx, Inc. reported EPS of $0.12, missing estimates by -50.8%, and revenue of $108.39M, 2.92% above expectations.
How did the market react to CareDx, Inc.'s Q4 2025 earnings?
The stock price moved down -1.85%, changed from $20.57 before the earnings release to $20.19 the day after.
When is CareDx, Inc. expected to report next?
The next earning report is scheduled for Apr 30, 2026.
What are the forecasts for CareDx, Inc.'s next earnings report?
Based on 11
analysts, CareDx, Inc. is expected to report EPS of $0.13 and revenue of $104.33M for Q1 2026.